Asheesh Shipstone, MD in Kingsport, TN ...

Dr. Asheesh Shipstone

Claim this profile

Wellmont Medical Associates-Bristol

Studies Breast Cancer
Studies Breast cancer
33 reported clinical trials
62 drugs studied

Area of expertise

1Breast Cancer
Asheesh Shipstone has run 8 trials for Breast Cancer. Some of their research focus areas include:
HER2 positive
Stage IV
Stage III
2Breast Cancer
Asheesh Shipstone has run 8 trials for Breast cancer. Some of their research focus areas include:
HER2 positive
Stage IV
Stage III

Affiliated Hospitals

Image of trial facility.
Wellmont Medical Associates-Bristol
Image of trial facility.
Ballad Health Cancer Care - Kingsport

Clinical Trials Asheesh Shipstone is currently running

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Image of trial facility.

Mobile Health

for Breast Cancer

This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria

More about Asheesh Shipstone

Clinical Trial Related6 years of experience running clinical trials · Led 33 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Asheesh Shipstone has experience with
  • Atezolizumab
  • Paclitaxel
  • Fluorouracil
  • Bevacizumab
  • Carboplatin
  • Gemcitabine Hydrochloride

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Asheesh Shipstone specialize in?
Is Asheesh Shipstone currently recruiting for clinical trials?
Are there any treatments that Asheesh Shipstone has studied deeply?
What is the best way to schedule an appointment with Asheesh Shipstone?
What is the office address of Asheesh Shipstone?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security